Uniform Susceptibility of Various Strains of Coccidioides immitis to Amphotericin B
AUTOR(ES)
Collins, M. S.
RESUMO
The susceptibility of 12 strains of Coccidioides immitis to amphotericin B (amB) was studied in vitro and in vivo. The minimal inhibitory concentration (MIC) of the mycelial phase of these strains was 0.078 to 0.16 μg/ml after 3 days of incubation, but by 15 days all strains were inhibited by 2.5 μg/ml. Mice infected intraperitoneally with these strains were sucessfully treated with 0.5 mg of amB per kg per day. These strains included several studied by others and which reportedly varied widely in susceptibility (MIC from 0.24 to 24.01 μg/ml) to amB. Four of these strains representing this putative broad range of susceptibility were used to infect mice intranasally. Regardless of infecting strain, mice were sucessfully treated with 0.38, 0.75, and 1.5 mg/kg, but 0.19 mg/kg was only partially effective. Thus, in vivo as well as in vitro there was a uniform response of C. immitis strains to amB.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352127Documentos Relacionados
- In Vitro Inhibition of Coccidioides Immitis Strains with Amphotericin B Plus Rifampin
- In Vitro Activities of Free and Lipid Formulations of Amphotericin B and Nystatin against Clinical Isolates of Coccidioides immitis at Various Saprobic Stages
- Inhibition of Coccidioides immitis In Vitro and Enhancement of Anticoccidioidal Effects of Amphotericin B by Polymyxin B
- Effect of Amphotericin B and Rifampin Against Coccidioides immitis In Vitro and In Vivo1
- Importance of Interleukin-10 in Genetic Susceptibility of Mice to Coccidioides immitis
